ARCHIVES

FDA Says Bristol’s UFT “Not Approvable” For Colorectal Cancer, Contrary To ODAC.

This article is from The Cancer Letter archive.

Vol. 27 No. 13 | March 30, 2001

Download PDF Visit The Full Archive

Related Articles

DCPC Board Votes To Keep Women’s Health Trial Alive, At Least For Now; Issue Goes To NCAB

September 25, 1987

Pitt Cancer Center Director Herberman Issues “Precautionary Advice” On Cell Phone Use.

July 25, 2008

NCI Not Following Congress Mandate, Zubrod Contends

April 28, 1978

In Brief: Candlelight Vigil At Lincoln Memorial Planned For Night Before Cancer March

March 6, 1998

FDA Approves Xtandi For Late-Stage Castration-Resistant Prostate Cancer

August 31, 2012

Book By Clinical Researcher Makes Case For Nationwide Reforms

July 30, 1993